CAPR 10-Q: SEC filing
Capricor Therapeutics
Filed with the SEC on · accession 0001104659-26-125355
CAPR filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -9.9% by the first close after the filing.
Summary of the filing
Capricor Therapeutics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures including ATM program activity and equity incentive plan details.
Key details
How CAPR stock reacted
Close before
$9.85
Nov 9, 2026
First close after
-9.95%
$8.87
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CAPR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CAPR?
Click hereFrequently asked questions
What did CAPR file with the SEC on Nov 10, 2026?
CAPR filed a 10-Q (SEC filing). Capricor Therapeutics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures including ATM program activity and equity incentive plan details.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did CAPR stock react to this filing?
CAPR closed at $9.85 before the filing and $8.87 on Nov 10, 2026 (-9.95%).
Other CAPR SEC filings
- 8-K · SEC filingNov 10, 2026
- SCHEDULE 13G/A · SEC filingOct 14, 2026
- SCHEDULE 13G · SEC filingSep 14, 2026
- 8-K · SEC filingAug 24, 2026
- SCHEDULE 13G · SEC filingAug 19, 2026
- 10-Q · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 13, 2026
- 8-K · Fda rejectionJul 30, 2026
- 8-K · Fda approvalJul 29, 2026
Get alerts when CAPR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days